In Estonia, a recent survey conducted by Kantar Emor revealed that 82% of residents purchased prescription medications over the past year, a trend that mirrors data from previous years. However, the survey also highlighted that 30% of adults chose not to fill prescriptions for various reasons, indicating potential barriers in accessing necessary medications. Getter Hark, the head of the medicinal reimbursement service at Tervisekassa, notes that while prescription purchase rates are stable, the list of subsidized medications has expanded, providing more treatment options for patients suffering from severe or rare diseases.

The Estonian Health Insurance Fund, Tervisekassa, reimbursed a total of 254 million euros for medications last year, which emphasizes the financial implications of prescription medication purchases on both the healthcare system and individuals. The steady rate of prescriptions filled suggests a commitment among the population to adhere to prescribed treatments, yet the significant number of residents who do not purchase their prescribed medications raises concerns about access, cost, and patients' understanding of their medical needs. Hark pointed out that investments in subsidized drugs have increased, revealing the health insurance system's efforts to make necessary treatments more available to the public.

Given these findings, it is crucial to address the reasons behind the avoidance of prescription purchases. The challenges may include financial constraints, lack of awareness about available subsidies, or confidence in alternative treatments. Further analysis is required to understand the dynamics of prescription medication usage in Estonia and to ensure that those who need medication can access it without undue financial burden or hesitation.